English  |  正體中文  |  简体中文  |  总笔数 :2817996  
造访人次 :  27966192    在线人数 :  290
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"sun n y"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 1-50 / 54 (共2页)
1 2 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2022-08-19T00:20:28Z Eg5 as a prognostic biomarker and potential therapeutic target for hepatocellular carcinoma Sun N.-Y.; CHIUN HSU; Cheng A.-L.; Shao Y.-Y.; Jeng Y.-M.; Wu Y.-M.; Hsu C.-H.; Hsu H.-C.; Lin Z.-Z.
臺大學術典藏 2022-06-10T06:10:54Z Eg5 as a prognostic biomarker and potential therapeutic target for hepatocellular carcinoma Shao Y.-Y.; Sun N.-Y.; Jeng Y.-M.; Wu Y.-M.; Hsu C.; Hsu C.-H.; Hsu H.-C.; Cheng A.-L.; ZHONG-ZHE LIN
臺大學術典藏 2022-02-21T02:04:34Z Eg5 as a prognostic biomarker and potential therapeutic target for hepatocellular carcinoma Shao Y.-Y.; Sun N.-Y.; Jeng Y.-M.; Wu Y.-M.; Hsu C.; Hsu C.-H.; Hsu H.-C.; ANN-LII CHENG; Lin Z.-Z.
臺大學術典藏 2022-02-16T03:16:57Z Eg5 as a prognostic biomarker and potential therapeutic target for hepatocellular carcinoma YU-YUN SHAO; Sun N.-Y.; Jeng Y.-M.; Wu Y.-M.; Hsu C.; Hsu C.-H.; Hsu H.-C.; Cheng A.-L.; Lin Z.-Z.
臺大學術典藏 2022-02-14T07:10:49Z Eg5 as a prognostic biomarker and potential therapeutic target for hepatocellular carcinoma Shao Y.-Y.; Sun N.-Y.; YUNG-MING JENG; Wu Y.-M.; Hsu C.; Hsu C.-H.; Hsu H.-C.; Cheng A.-L.; Lin Z.-Z.
臺大學術典藏 2022-02-07T03:29:05Z Eg5 as a prognostic biomarker and potential therapeutic target for hepatocellular carcinoma Shao Y.-Y.; Sun N.-Y.; Jeng Y.-M.; Wu Y.-M.; Hsu C.; CHIH-HUNG HSU; Hsu H.-C.; Cheng A.-L.; Lin Z.-Z.
臺大學術典藏 2022-01-24T06:05:35Z Eg5 as a prognostic biomarker and potential therapeutic target for hepatocellular carcinoma Shao Y.-Y.; Sun N.-Y.; Jeng Y.-M.; Wu Y.-M.; CHIUN HSU; Hsieh C.-H.; Hsu H.-C.; Cheng A.-L.; Lin Z.-Z.
臺大學術典藏 2021-10-27T07:48:58Z mTOR inhibitors can enhance the anti-tumor effects of DNA vaccines through modulating dendritic cell function in the tumor microenvironment Chen Y.-L.; Lin H.-W.; Sun N.-Y.; JR-CHI YIE; Hung H.-C.; Chen C.-A.; Sun W.-Z.; Cheng W.-F.
臺大學術典藏 2021-09-27T06:18:41Z Blockade of PD-L1 enhances cancer immunotherapy by regulating dendritic cell maturation and macrophage polarization Sun N.-Y.; Chen Y.-L.; Wu W.-Y.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Tai Y.-J.; HENG-CHENG HSU; Chen C.-A.; Sun W.-Z.; Cheng W.-F.
臺大學術典藏 2021-03-10T02:34:31Z Blockade of PD-L1 enhances cancer immunotherapy by regulating dendritic cell maturation and macrophage polarization Sun N.-Y.;Chen Y.-L.;Wu W.-Y.;Lin H.-W.;Chiang Y.-C.;Chang C.-F.;Tai Y.-J.;Heng-Cheng Hsu;Chen C.-A.;Sun W.-Z.;Cheng W.-F.; Sun N.-Y.; Chen Y.-L.; Wu W.-Y.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Tai Y.-J.; HENG-CHENG HSU; Chen C.-A.; Sun W.-Z.; Cheng W.-F.
臺大學術典藏 2021-02-04T02:39:52Z Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation Yu-Li Chen;Chang M.-C.;Chiang Y.-C.;Lin H.-W.;Sun N.-Y.;Chen C.-A.;Sun W.-Z.;Cheng W.-F.; YU-LI CHEN; Chang M.-C.; Chiang Y.-C.; Lin H.-W.; Sun N.-Y.; Chen C.-A.; Sun W.-Z.; Cheng W.-F.
臺大學術典藏 2021-02-04T02:39:51Z CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells Lin H.-W.;Chiang Y.-C.;Sun N.-Y.;Yu-Li Chen;Chang C.-F.;Tai Y.-J.;Chen C.-A.;Cheng W.-F.; Lin H.-W.; Chiang Y.-C.; Sun N.-Y.; YU-LI CHEN; Chang C.-F.; Tai Y.-J.; Chen C.-A.; Cheng W.-F.
臺大學術典藏 2021-02-04T02:39:50Z Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes Sun N.-Y.;Yu-Li Chen;Lin H.-W.;Chiang Y.-C.;Chang C.-F.;Tai Y.-J.;Chen C.-A.;Sun W.-Z.;Chien C.-L.;Cheng W.-F.; Sun N.-Y.; YU-LI CHEN; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; Sun W.-Z.; Chien C.-L.; Cheng W.-F.
臺大學術典藏 2021-02-04T02:39:50Z mTOR inhibitors can enhance the anti-tumor effects of DNA vaccines through modulating dendritic cell function in the tumor microenvironment Yu-Li Chen;Lin H.-W.;Sun N.-Y.;Yie J.-C.;Hung H.-C.;Chen C.-A.;Sun W.-Z.;Cheng W.-F.; YU-LI CHEN; Lin H.-W.; Sun N.-Y.; Yie J.-C.; Hung H.-C.; Chen C.-A.; Sun W.-Z.; Cheng W.-F.
臺大學術典藏 2021-02-04T02:39:49Z Blockade of PD-L1 enhances cancer immunotherapy by regulating dendritic cell maturation and macrophage polarization Sun N.-Y.;Yu-Li Chen;Wu W.-Y.;Lin H.-W.;Chiang Y.-C.;Chang C.-F.;Tai Y.-J.;Hsu H.-C.;Chen C.-A.;Sun W.-Z.;Cheng W.-F.; Sun N.-Y.; YU-LI CHEN; Wu W.-Y.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Tai Y.-J.; Hsu H.-C.; Chen C.-A.; Sun W.-Z.; Cheng W.-F.
臺大學術典藏 2020-05-24T06:00:16Z Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation YU-LI CHEN; Chang M.-C.; Chiang Y.-C.; Lin H.-W.; Sun N.-Y.; Chen C.-A.; Sun W.-Z.; Cheng W.-F.
臺大學術典藏 2020-05-24T06:00:15Z CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells Lin H.-W.; Chiang Y.-C.; Sun N.-Y.; YU-LI CHEN; Chang C.-F.; Tai Y.-J.; Chen C.-A.; Cheng W.-F.
臺大學術典藏 2020-05-24T06:00:14Z mTOR inhibitors can enhance the anti-tumor effects of DNA vaccines through modulating dendritic cell function in the tumor microenvironment YU-LI CHEN; Lin H.-W.; Sun N.-Y.; Yie J.-C.; Hung H.-C.; Chen C.-A.; Sun W.-Z.; Cheng W.-F.
臺大學術典藏 2020-05-24T06:00:14Z Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes Sun N.-Y.; YU-LI CHEN; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; Sun W.-Z.; Chien C.-L.; Cheng W.-F.
臺大學術典藏 2020-05-24T06:00:13Z Blockade of PD-L1 enhances cancer immunotherapy by regulating dendritic cell maturation and macrophage polarization Sun N.-Y.; YU-LI CHEN; Wu W.-Y.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Tai Y.-J.; Hsu H.-C.; Chen C.-A.; Sun W.-Z.; Cheng W.-F.
臺大學術典藏 2020-02-27T01:50:03Z Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes Tai Y.-J.; Chen C.-A.; Sun W.-Z.; CHUNG-LIANG CHIEN; Cheng W.-F.; Sun N.-Y.;Chen Y.-L.;Lin H.-W.;Chiang Y.-C.;Chang C.-F.;Tai Y.-J.;Chen C.-A.;Sun W.-Z.;Chung-Liang Chien;Cheng W.-F.; Sun N.-Y.; Chen Y.-L.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.
臺大學術典藏 2020-02-27T01:50:03Z Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes Tai Y.-J.; Chen C.-A.; Sun W.-Z.; CHUNG-LIANG CHIEN; Cheng W.-F.; Sun N.-Y.;Chen Y.-L.;Lin H.-W.;Chiang Y.-C.;Chang C.-F.;Tai Y.-J.;Chen C.-A.;Sun W.-Z.;Chung-Liang Chien;Cheng W.-F.; Sun N.-Y.; Chen Y.-L.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.
臺大學術典藏 2020-02-14T08:50:31Z Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation Chen Y.-L; Chang M.-C; YING-CHENG CHIANG; Lin H.-W; Sun N.-Y; Chen C.-A; Sun W.-Z; Cheng W.-F.
臺大學術典藏 2020-02-14T08:50:30Z CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells Tai Y.-J; Chen C.-A; Cheng W.-F.; Lin H.-W; YING-CHENG CHIANG; Sun N.-Y; Chen Y.-L; Chang C.-F
臺大學術典藏 2020-02-14T08:50:29Z Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes Sun N.-Y; Chen Y.-L; Lin H.-W; YING-CHENG CHIANG; Chang C.-F; Tai Y.-J; Chen C.-A; Sun W.-Z; Chien C.-L; Cheng W.-F.
臺大學術典藏 2020-02-14T02:49:39Z Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation Chen Y.-L.;Chang M.-C.;Chiang Y.-C.;Lin H.-W.;Sun N.-Y.;Chen C.-A.;Sun W.-Z.;Wen-Fang Cheng; Chen Y.-L.; Chang M.-C.; Chiang Y.-C.; Lin H.-W.; Sun N.-Y.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG
臺大學術典藏 2020-02-14T02:49:39Z Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation Chen Y.-L.;Chang M.-C.;Chiang Y.-C.;Lin H.-W.;Sun N.-Y.;Chen C.-A.;Sun W.-Z.;Wen-Fang Cheng; Chen Y.-L.; Chang M.-C.; Chiang Y.-C.; Lin H.-W.; Sun N.-Y.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG
臺大學術典藏 2020-02-14T02:49:36Z CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells Lin H.-W.;Chiang Y.-C.;Sun N.-Y.;Chen Y.-L.;Chang C.-F.;Tai Y.-J.;Chen C.-A.;Wen-Fang Cheng; Lin H.-W.; Chiang Y.-C.; Sun N.-Y.; Chen Y.-L.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; WEN-FANG CHENG
臺大學術典藏 2020-02-14T02:49:36Z CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells Lin H.-W.;Chiang Y.-C.;Sun N.-Y.;Chen Y.-L.;Chang C.-F.;Tai Y.-J.;Chen C.-A.;Wen-Fang Cheng; Lin H.-W.; Chiang Y.-C.; Sun N.-Y.; Chen Y.-L.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; WEN-FANG CHENG
臺大學術典藏 2020-02-14T02:49:34Z Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes Sun N.-Y.;Chen Y.-L.;Lin H.-W.;Chiang Y.-C.;Chang C.-F.;Tai Y.-J.;Chen C.-A.;Sun W.-Z.;Chien C.-L.;Wen-Fang Cheng; Sun N.-Y.; Chen Y.-L.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; Sun W.-Z.; Chien C.-L.; WEN-FANG CHENG
臺大學術典藏 2020-02-14T02:49:34Z Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes Sun N.-Y.;Chen Y.-L.;Lin H.-W.;Chiang Y.-C.;Chang C.-F.;Tai Y.-J.;Chen C.-A.;Sun W.-Z.;Chien C.-L.;Wen-Fang Cheng; Sun N.-Y.; Chen Y.-L.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; Sun W.-Z.; Chien C.-L.; WEN-FANG CHENG
臺大學術典藏 2020-02-14T02:49:33Z mTOR inhibitors can enhance the anti-tumor effects of DNA vaccines through modulating dendritic cell function in the tumor microenvironment WEN-FANG CHENG; Chen C.-A.; Sun W.-Z.; Chen Y.-L.;Lin H.-W.;Sun N.-Y.;Yie J.-C.;Hung H.-C.;Chen C.-A.;Sun W.-Z.;Wen-Fang Cheng; Chen Y.-L.; Lin H.-W.; Sun N.-Y.; Yie J.-C.; Hung H.-C.
臺大學術典藏 2020-02-14T02:49:33Z mTOR inhibitors can enhance the anti-tumor effects of DNA vaccines through modulating dendritic cell function in the tumor microenvironment WEN-FANG CHENG; Chen C.-A.; Sun W.-Z.; Chen Y.-L.;Lin H.-W.;Sun N.-Y.;Yie J.-C.;Hung H.-C.;Chen C.-A.;Sun W.-Z.;Wen-Fang Cheng; Chen Y.-L.; Lin H.-W.; Sun N.-Y.; Yie J.-C.; Hung H.-C.
臺大學術典藏 2020-02-06T05:21:50Z Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation WEN-FANG CHENG;Sun W.-Z.;Chen C.-A.;Sun N.-Y.;Lin H.-W.;Chiang Y.-C.;Chang M.-C.;Chen Y.-L.; Chen Y.-L.; Chang M.-C.; Chiang Y.-C.; Lin H.-W.; Sun N.-Y.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG; Chen Y.-L.; Chang M.-C.; Chiang Y.-C.; Lin H.-W.; Sun N.-Y.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG
臺大學術典藏 2020-02-06T05:21:50Z Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation WEN-FANG CHENG;Sun W.-Z.;Chen C.-A.;Sun N.-Y.;Lin H.-W.;Chiang Y.-C.;Chang M.-C.;Chen Y.-L.; Chen Y.-L.; Chang M.-C.; Chiang Y.-C.; Lin H.-W.; Sun N.-Y.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG; Chen Y.-L.; Chang M.-C.; Chiang Y.-C.; Lin H.-W.; Sun N.-Y.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG
臺大學術典藏 2020-02-06T05:21:50Z Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation WEN-FANG CHENG;Sun W.-Z.;Chen C.-A.;Sun N.-Y.;Lin H.-W.;Chiang Y.-C.;Chang M.-C.;Chen Y.-L.; Chen Y.-L.; Chang M.-C.; Chiang Y.-C.; Lin H.-W.; Sun N.-Y.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG; Chen Y.-L.; Chang M.-C.; Chiang Y.-C.; Lin H.-W.; Sun N.-Y.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG
臺大學術典藏 2020-02-06T05:21:48Z CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells WEN-FANG CHENG;Chen C.-A.;Tai Y.-J.;Chang C.-F.;Chen Y.-L.;Sun N.-Y.;Chiang Y.-C.;Lin H.-W.; Lin H.-W.; Chiang Y.-C.; Sun N.-Y.; Chen Y.-L.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; WEN-FANG CHENG; Lin H.-W.; Chiang Y.-C.; Sun N.-Y.; Chen Y.-L.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; WEN-FANG CHENG
臺大學術典藏 2020-02-06T05:21:48Z CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells WEN-FANG CHENG;Chen C.-A.;Tai Y.-J.;Chang C.-F.;Chen Y.-L.;Sun N.-Y.;Chiang Y.-C.;Lin H.-W.; Lin H.-W.; Chiang Y.-C.; Sun N.-Y.; Chen Y.-L.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; WEN-FANG CHENG; Lin H.-W.; Chiang Y.-C.; Sun N.-Y.; Chen Y.-L.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; WEN-FANG CHENG
臺大學術典藏 2020-02-06T05:21:48Z CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells WEN-FANG CHENG;Chen C.-A.;Tai Y.-J.;Chang C.-F.;Chen Y.-L.;Sun N.-Y.;Chiang Y.-C.;Lin H.-W.; Lin H.-W.; Chiang Y.-C.; Sun N.-Y.; Chen Y.-L.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; WEN-FANG CHENG; Lin H.-W.; Chiang Y.-C.; Sun N.-Y.; Chen Y.-L.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; WEN-FANG CHENG
臺大學術典藏 2020-02-06T05:21:45Z Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes WEN-FANG CHENG;Chien C.-L.;Sun W.-Z.;Chen C.-A.;Tai Y.-J.;Chang C.-F.;Chiang Y.-C.;Lin H.-W.;Chen Y.-L.;Sun N.-Y.; Sun N.-Y.; Chen Y.-L.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; Sun W.-Z.; Chien C.-L.; WEN-FANG CHENG; Sun N.-Y.; Chen Y.-L.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; Sun W.-Z.; Chien C.-L.; WEN-FANG CHENG
臺大學術典藏 2020-02-06T05:21:45Z Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes WEN-FANG CHENG;Chien C.-L.;Sun W.-Z.;Chen C.-A.;Tai Y.-J.;Chang C.-F.;Chiang Y.-C.;Lin H.-W.;Chen Y.-L.;Sun N.-Y.; Sun N.-Y.; Chen Y.-L.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; Sun W.-Z.; Chien C.-L.; WEN-FANG CHENG; Sun N.-Y.; Chen Y.-L.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; Sun W.-Z.; Chien C.-L.; WEN-FANG CHENG
臺大學術典藏 2020-02-06T05:21:45Z Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes WEN-FANG CHENG;Chien C.-L.;Sun W.-Z.;Chen C.-A.;Tai Y.-J.;Chang C.-F.;Chiang Y.-C.;Lin H.-W.;Chen Y.-L.;Sun N.-Y.; Sun N.-Y.; Chen Y.-L.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; Sun W.-Z.; Chien C.-L.; WEN-FANG CHENG; Sun N.-Y.; Chen Y.-L.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; Sun W.-Z.; Chien C.-L.; WEN-FANG CHENG
臺大學術典藏 2020-02-06T05:21:43Z mTOR inhibitors can enhance the anti-tumor effects of DNA vaccines through modulating dendritic cell function in the tumor microenvironment WEN-FANG CHENG;Sun W.-Z.;Chen C.-A.;Hung H.-C.;Yie J.-C.;Sun N.-Y.;Lin H.-W.;Chen Y.-L.; Chen Y.-L.; Lin H.-W.; Sun N.-Y.; Yie J.-C.; Hung H.-C.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG; Chen Y.-L.; Lin H.-W.; Sun N.-Y.; Yie J.-C.; Hung H.-C.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG
臺大學術典藏 2020-02-06T05:21:43Z mTOR inhibitors can enhance the anti-tumor effects of DNA vaccines through modulating dendritic cell function in the tumor microenvironment WEN-FANG CHENG;Sun W.-Z.;Chen C.-A.;Hung H.-C.;Yie J.-C.;Sun N.-Y.;Lin H.-W.;Chen Y.-L.; Chen Y.-L.; Lin H.-W.; Sun N.-Y.; Yie J.-C.; Hung H.-C.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG; Chen Y.-L.; Lin H.-W.; Sun N.-Y.; Yie J.-C.; Hung H.-C.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG
臺大學術典藏 2020-02-06T05:21:43Z mTOR inhibitors can enhance the anti-tumor effects of DNA vaccines through modulating dendritic cell function in the tumor microenvironment WEN-FANG CHENG;Sun W.-Z.;Chen C.-A.;Hung H.-C.;Yie J.-C.;Sun N.-Y.;Lin H.-W.;Chen Y.-L.; Chen Y.-L.; Lin H.-W.; Sun N.-Y.; Yie J.-C.; Hung H.-C.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG; Chen Y.-L.; Lin H.-W.; Sun N.-Y.; Yie J.-C.; Hung H.-C.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG
臺大學術典藏 2020-01-22T07:50:24Z Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation Chiang Y.-C.; Lin H.-W.; Sun N.-Y.; CHI-AN CHEN; Sun W.-Z.; Cheng W.-F.; Chen Y.-L.;Chang M.-C.;Chiang Y.-C.;Lin H.-W.;Sun N.-Y.;Chi-An Chen;Sun W.-Z.;Cheng W.-F.; Chen Y.-L.; Chang M.-C.
臺大學術典藏 2020-01-22T07:50:24Z Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation Chiang Y.-C.; Lin H.-W.; Sun N.-Y.; CHI-AN CHEN; Sun W.-Z.; Cheng W.-F.; Chen Y.-L.;Chang M.-C.;Chiang Y.-C.;Lin H.-W.;Sun N.-Y.;Chi-An Chen;Sun W.-Z.;Cheng W.-F.; Chen Y.-L.; Chang M.-C.
臺大學術典藏 2020-01-22T07:50:23Z CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells Lin H.-W.;Chiang Y.-C.;Sun N.-Y.;Chen Y.-L.;Chang C.-F.;Tai Y.-J.;Chi-An Chen;Cheng W.-F.; Lin H.-W.; Chiang Y.-C.; Sun N.-Y.; Chen Y.-L.; Chang C.-F.; Tai Y.-J.; CHI-AN CHEN; Cheng W.-F.
臺大學術典藏 2020-01-22T07:50:23Z CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells Lin H.-W.;Chiang Y.-C.;Sun N.-Y.;Chen Y.-L.;Chang C.-F.;Tai Y.-J.;Chi-An Chen;Cheng W.-F.; Lin H.-W.; Chiang Y.-C.; Sun N.-Y.; Chen Y.-L.; Chang C.-F.; Tai Y.-J.; CHI-AN CHEN; Cheng W.-F.
臺大學術典藏 2020-01-22T07:50:22Z mTOR inhibitors can enhance the anti-tumor effects of DNA vaccines through modulating dendritic cell function in the tumor microenvironment Chen Y.-L.;Lin H.-W.;Sun N.-Y.;Yie J.-C.;Hung H.-C.;Chi-An Chen;Sun W.-Z.;Cheng W.-F.; Chen Y.-L.; Lin H.-W.; Sun N.-Y.; Yie J.-C.; Hung H.-C.; CHI-AN CHEN; Sun W.-Z.; Cheng W.-F.

显示项目 1-50 / 54 (共2页)
1 2 > >>
每页显示[10|25|50]项目